CM
SBC

Crestline Management’s SBC Medical Group SBC Stock Holding History

Crestline Management’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-40,000
Closed -$410K – 214
2022
Q4 		$410K Buy
+40,000
New +$405K 0.06% 146

Other funds holding SBC

PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Crestline Management's SBC Position: Q1 2023 in Review

Crestline Management sold out of SBC Medical Group (SBC) in Q1 2023, closing a stake of 40,000 shares — an estimated $410K sold.

Crestline Management first reported a position in SBC in Q4 2022 and held it in 1 quarter. The position peaked at $410K in Q4 2022. 38 funds tracked by Wall St. Rank hold SBC as of Q1 2023.

  • Crestline Management reported no remaining SBC Medical Group position as of Q1 2023 after selling out during the quarter.
  • Crestline Management sold 40,000 SBC Medical Group shares in Q1 2023, an estimated $410K.
  • Crestline Management first reported a position in SBC Medical Group in Q4 2022 and held it in 1 quarter.
  • Crestline Management's SBC Medical Group position peaked at $410K in Q4 2022.
  • 38 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2023.

Based on Crestline Management's 13F filing for Q1 2023, filed 15 May 2023.